Archives

Johnson & Johnson study shows TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to demonstrate efficacy in perianal fistulizing Crohn’s disease

B TREMFYA® demonstrated significantly higher rates of combined fistula remission – complete external closure of draining fistulas and absence of fluid collection on MRI –… Login to continue reading Login…

Read MoreJohnson & Johnson study shows TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to demonstrate efficacy in perianal fistulizing Crohn’s disease

University of Virginia coxswain and volunteer firefighter and EMT Shelby Bavin named captain of the Allstate NACDA Spring Good Works Team

B Bavin is devoted to supporting Charlottesville families, serving as the first volunteer firefighter and EMT to lead the Good Works Team, which recognizes 20… Login to continue reading Login…

Read MoreUniversity of Virginia coxswain and volunteer firefighter and EMT Shelby Bavin named captain of the Allstate NACDA Spring Good Works Team